Guest guest Posted July 1, 2007 Report Share Posted July 1, 2007 OK, so here comes a mini-lesson in molecular immunology! You might like to draw this out as I describe it so it will be easier to understand. Each antibody molecule is Y-shaped. The V part of the Y is the ab fragment (Fab) and the straight stem of the Y is the c fragment (Fc). The Fab carries the specificity allowing the antibody molecule to bind to an antigen (which can be an allergen in the case of IgE) but the Fc does not. IgE's Fc is the region that binds to the mast cell, thereby triggering histamine release from the mast cell and getting the allergic cascade started. Both the Fab and the Fc also have regions specific to the class of antibody (IgG or IgE or others). Xolair recognizes and binds only to IgE's Fc, so that the IgE can no longer bind to mast cells, thus preventing the release of histamine and starting the allergic cascade. The mast cell's binding site for IgE's Fc is called the Fc receptor and is " expressed " (exposed) on the external surface of the membrane enclosing the cell. The precursors to mast cells are called basophils and they also have Fc receptors for IgE. Interestingly, and this may be what you saw in the report about Xolair, the expression (presence) of the Fc receptors on basophils are decreased in the presence of Xolair. This is the basis for the theory that Xolair might lessen allergic immune responses by a separate mechanism in addition to simply directly inactivating IgE. The thinking is that since the basophils' Fc receptor expression is lowered by Xolair, perhaps the mast cells that develop from those basophils might also have decreased Fc receptor expression so that besides Xolair binding up and inactivating IgE, Xolair treatment might also decrease the number of Fc receptors on mast cells. That reduction in Fc receptors would be expected to reduce the chances that any intact IgE could bind to mast cells. I hope that's clear - please let me know if it's not so I can try to explain it better. Fran --- In , " instdesgn1 " <instdesgn1@...> wrote: > > Reading an FDA report about Xolair I came across something about " Fc > Receptor Expression. " It seems to be somehow associated with IgG which > I thought had something to do with immunity but don't remember for > sure. Does anyone know the significance of this term in the report? > > Thx > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 1, 2007 Report Share Posted July 1, 2007 wow, thanks for that in-depth description - sounds great to me! > > > > Reading an FDA report about Xolair I came across something about " Fc > > Receptor Expression. " It seems to be somehow associated with IgG > which > > I thought had something to do with immunity but don't remember for > > sure. Does anyone know the significance of this term in the report? > > > > Thx > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 1, 2007 Report Share Posted July 1, 2007 Fran, I have read somewhere that there is some thinking in the Xolair establishment that Xolair may have anti-inflammatory properties. I have thought that the decrease in inflammation is simply a result of the decrease in allergic cascade activity due to Xolair preventing IgE from binding to the mast cell. If there is also a decrease in Fc receptor expression on the mast cell, might that also attribute to a decrease in inflammation? Just trying to wrap my brain around science, a difficult thing for an English major. Thanks so much for the clear way you explain things to all of us lay people. I'm sure you are happy to be retired, but I am sure children and families are missing your services! Addy > > > > Reading an FDA report about Xolair I came across something about " Fc > > Receptor Expression. " It seems to be somehow associated with IgG > which > > I thought had something to do with immunity but don't remember for > > sure. Does anyone know the significance of this term in the report? > > > > Thx > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 2, 2007 Report Share Posted July 2, 2007 Yes, as far as I know the thinking about reduction of inflammation is based on the information about the decrease in Fc receptors. Histamine realease causes enough problems on its own but also triggers other immune events that worsen the inflammation. Thanks for your kind comments. Actually, I'm disabled rather than retired, due to multiple medical problems including asthma and chronic fatigue, and I'm very sad about no longer being in practice. I really miss my kids and families. I do some volunteer work with medically indigent kids and grieving kids and that does help a bit but there's a big hole in my heart where my patients used to be. Fran > > > > > > Reading an FDA report about Xolair I came across something about " Fc > > > Receptor Expression. " It seems to be somehow associated with IgG > > which > > > I thought had something to do with immunity but don't remember for > > > sure. Does anyone know the significance of this term in the report? > > > > > > Thx > > > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.